Led by Experience
Backed by Vision

Dr. Steve Ferguson is a nationally recognized leader in ophthalmic innovation, with nearly four decades of experience transforming vision care delivery. As founder of Dunes Eye Consultants and Dunes LASIK Center, he has built a premier practice that combines cutting-edge technology with evidence-based patient care. A 1987 honors graduate from the University of Houston College of Optometry, Dr. Ferguson, with clinical expertise spanning dry eye treatment, glaucoma management, diabetic eye health and myopia control, complemented by leadership roles as a medical board advisor for eyeBrain Medical and TearScience. Dr. Ferguson’s commitment to advancing the profession includes participation in clinical research, authorship of numerous peer-reviewed articles, and delivery of over 20 invited lectures nationwide. His unique ability to translate complex clinical concepts into actionable practice improvements has made him a trusted partner for eyecare providers seeking operational excellence and enhanced patient outcomes.

Brian Regan brings decades of MedTech leadership excellence, combining deep operational expertise with a proven track record of delivering strong commercial results and investor value. His career spans successful ventures in disruptive and fast-following medical technology, including a notable 2017 Fortune 50 strategic exit and leadership role in a top-five IPO in the segment. With comprehensive experience leading strategy, marketing, sales, market access and operations, Brian has consistently driven growth in complex healthcare environments. He holds a bachelor’s degree in finance and economics from Loyola University of Chicago and a master’s degree in marketing from Northwestern’s J.L. Kellogg Graduate School of Management. His strategic vision and execution capabilities position him to scale operations while maintaining the clinical excellence and innovation that eye care practices demand in today’s rapidly evolving healthcare landscape.

John Lawrence is an accomplished entrepreneur and strategic advisor with nearly three decades of experience navigating complex healthcare transactions and regulatory environments. As a founding employee of NovaMed, he played a pivotal role in growing the healthcare services company from inception to a publicly traded enterprise with nearly 800 employees operating in 20 states before its acquisition by HIG Capital. During his 19-year tenure, John structured and negotiated over 100 acquisitions and divestitures, developing deep expertise in partnership development, regulatory compliance and value creation through strategic transactions. A graduate of the University of Michigan and Washington University in St. Louis, John brings invaluable experience in pursuing business opportunities through uncharted waters – a critical capability for eye care organizations navigating industry consolidation, regulatory changes and growth opportunities in today’s dynamic market.

Bailey Hawn is a results-driven business leader with a proven track record of building scalable growth strategies across software technology and healthtech industries. As Director of Partnerships and Chief of Staff at OpenLoop, he has established partnership programs with 25 new partners and 6 resellers, signed over $26 million in projected ARR for new accounts and supported a successful Series A raise while managing investor relations. His operational experience includes establishing an international development office with 15 employees and implementing new EHR systems, sales tools and outbound strategies that drive measurable improvement. Previously, Bailey served as Associate Director of Business Development at Digital Artefacts (acquired by Clinical Ink) and held leadership roles at BrainBaseline and DriveELD. He holds an MBA in Healthcare, Public & Private Leadership from Johns Hopkins University, along with degrees in Enterprise Leadership and Recreation and Sports Management from The University of Iowa. His unique combination of healthcare expertise, technology acumen and entrepreneurial experience positions him to develop innovative marketing strategies that resonate with eye care practices while driving sustainable growth.

As Chief Technology Officer at Sterling, Chris Cyr brings decades of strategic technology leadership forged in the most demanding environments – from mission-critical space programs to enterprise-scale digital transformation initiatives. A US Air Force veteran with Top Secret clearance, his career trajectory reflects a consistent ability to bridge cutting-edge innovation with operational excellence, including pivotal roles at Oracle and United Space Alliance. This foundation in high-stakes technical leadership, combined with deep expertise in AI/ML, quantum computing and enterprise architecture has positioned him as a trusted advisor to global technology leaders including NVIDIA, Dell, Intel, AMD, HPE and Cisco. His unique perspective – honed through years of translating complex technological capabilities into strategic business advantage – enables him to see beyond the technical possibilities to the practical pathways that drive measurable outcomes. At AVTRMed, Inc., Cyr leverages this rare combination of bleeding-edge technical vision and real-world implementation expertise to guide the company’s technology strategy, ensuring that innovation translates directly into market differentiation and sustainable competitive advantage.

Tom Chirillo brings nearly four decades of sales and marketing leadership in the eyecare industry, with a proven track record of driving transformational growth. As former Chief Commercial Officer at neurolens and Senior Vice President of Sales and Marketing at TearScience, he spearheaded a complete business model transformation that significantly accelerated sales and customer acquisition, ultimately leading to a successful company acquisition. His strategic vision was instrumental during the first wave of eyecare consolidation as part of the founding management team at NovaMed, where he spent 16 years guiding the company from inception through its initial public offering. Tom’s expertise in market development, strategic partnerships and commercialization strategy has consistently delivered measurable results for innovative eyecare technologies. His deep industry relationships and understanding of both independent practices and private equity-backed platforms make him uniquely positioned to drive sustainable revenue growth while supporting the clinical excellence and operational efficiency that define successful eye care organizations.

For over 25 years Dr. Boorady has been a transformational leader building and scaling organizations across the sector’s most influential companies. As former CEO of Euclid Vision Group, he orchestrated a global vision care platform spanning 10 subsidiaries, demonstrating his ability to manage complex, multi-faceted operations while driving cohesive growth strategies. His executive leadership experience includes pivotal roles at Johnson & Johnson Vision and Zeiss Meditec, Inc., where as Senior Vice President of Sales, Service and Marketing, he guided commercial strategy for one of eyecare’s most respected technology brands. As CEO of TearScience, Inc., Boorady combined operational expertise with entrepreneurial vision to advance innovative solutions in a rapidly evolving market. This rare combination of Fortune 500 corporate leadership and entrepreneurial execution gives him unique insight into both the strategic imperatives of large-scale organizations and the agility to bring disruptive technologies to market.